<DOC>
	<DOC>NCT01775189</DOC>
	<brief_summary>The main purpose of this study is to determine if oxycodone and naltrexone combination capsules (ALO-02) have the potential to be abused when they are crushed and snorted.</brief_summary>
	<brief_title>A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted</brief_title>
	<detailed_description>Abuse Liability Study</detailed_description>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Healthy subjects Nondependent, recreational opioid users. (Must use opioid for nontherapeutic purposes on at least 10 occassions within the last year and at least once in the 8 weeks before Visit 1 (Screening Visit). Must have experience with intranasal opioid administration (snorted opioid drugs on at least 3 occassions within the last year before Visit 1 (Screening Visit). Diagnosis of substance and/or alcohol dependence Subject has participated in, is currently participating in, or seeking treatment for substance and/or alcohol related disorder.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Relative abuse potential study</keyword>
	<keyword>Chronic pain</keyword>
	<keyword>oxycodone</keyword>
	<keyword>naltrexone</keyword>
	<keyword>opioid-related disorders</keyword>
	<keyword>drug abusers</keyword>
</DOC>